Novo Nordisk to present early-stage trial data for new diabetes drug at investor meeting

Novo Nordisk, maker of obesity drug Wegovy, on Thursday said it would present early-stage trial data for its highly anticipated pipeline drug, Amycretin, for treatment of Type 2 diabetes.